Modified Lentiviral Globin Gene Therapy for Pediatric β0/β0 Transfusion-Dependent β-Thalassemia: A Single-Center, Single-Arm Pilot Trial
Published: 18 April 2024| Version 1 | DOI: 10.17632/f9krjzw66k.1
Contributors:
Yujia Cai, Fangyuan HaoDescription
These data are the deposited supplemental information for the article entitled "Modified Lentiviral Globin Gene Therapy for Pediatric β0/β0 Transfusion-Dependent β-Thalassemia: A Single-Center, Single-Arm Pilot Trial" by Shiqi Li and Sikai Ling et al. in Cell Stem Cell. Dataset 1. The insertion site information of WBCs from the two patients and their drug products obtained by next-generation sequencing. Dataset 2. The impact of the HBBT87Q expression profile on PBMCs from four patient-derived samples at different time points after transplantation, assessed using single-cell RNA sequencing.
Files
Categories
Gene Therapy, Lentivirus, Beta Thalassemia
Funders
- Science and Technology Innovation Action Plan of ShanghaiGrant ID: 24Z510200306
- Key Forward-looking Fund from Shanghai Jiao Tong UniversityGrant ID: AF4150049
- Biomedical Major Project of Yunnan ProvinceGrant ID: 202102AA100011
- Young and Middle-aged Academic and Technical Leaders Reserve Talent Project of Yunnan ProvinceGrant ID: 202205AC160074